Jake Simson, Ph.D.

Jake Simson, Ph.D.

DirectoratSepterna· In proxies 2023–2025

Jake Simson, Ph.D. sits on 14 public boards.

Boards1

  • Tyra BiosciencesDirector · 3 yr on the boardIndependentNominating and Corporate Governance, Science and Technology (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. SepternaPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role +71%
  2. Janux TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Bicara TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  4. Tyra BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  5. Annual MeetingPublic company
    • Director? – PresentNo stock prices for these years
  6. Bicara Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Convergent Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Outpace Bio, Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. Parabilis Medicines, Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Septerna Inc.Public company
    • Director? – PresentNo stock prices for these years
  11. Tyra Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  12. Vivace Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  13. Dice Therapeutics, Inc.Public company · 3 yr
    • Director2020 – 2023 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?